Jazz Pharmaceuticals plc License Costs (Deprecated 2018-01-31)
Jazz Pharmaceuticals plc (JAZZ) reported License Costs (Deprecated 2018-01-31) of $1.00 million for the 3-month period ending 2013-09-30, per its 10-K filed 2014-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2014-02-25
- Jazz Pharmaceuticals plc license costs (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $1.00M.
- Jazz Pharmaceuticals plc license costs (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $4.00M.
| Period end | License Costs (Deprecated 2018-01-31) 3 month |
|---|---|
| 2013-09-30 | $1.00M 10-K · filed 2014-02-25 |
| 2013-03-31 | $4.00M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |